ANTIANGIOGENIC THERAPY IN ADVANCED LUNG ADENOCARCINOMA: EFFICACY AND KRAS MUTATION AS A PROGNOSTIC BIOMARKER

dc.contributor.advisor	Döme Balázs
dc.contributor.author	Ghimessy, Áron Kristóf
dc.date.accessioned	2021-03-10T13:41:11Z
dc.date.available	2021-03-10T13:41:11Z
dc.date.issued	2020
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/8689
dc.identifier.uri	doi:10.14753/SE.2020.2414
dc.title	ANTIANGIOGENIC THERAPY IN ADVANCED LUNG ADENOCARCINOMA: EFFICACY AND KRAS MUTATION AS A PROGNOSTIC BIOMARKER
dc.type	Dissertation
dc.date.updated	2021-03-02T14:33:58Z
dc.language.rfc3066	en
dc.rights.holder	NULL
dc.identifier.mtmt	31897857
dc.contributor.institution	Mellkassebészeti Klinika
dc.contributor.institution	Országos Onkológiai Intézet
dc.contributor.institution	Doktori Iskola